Author:
Chowdhury Fabliha Ahmed,Baker S. M. E. Al,Islam Mohammad Safiqul,Nahid Noor Ahmed,Mamun Mir Abdullah Al,Islam Md. Reazul,Apu Mohd Nazmul Hasan,Nahar Zabun,Ahmed Maizbha Uddin,Hasnat Abul
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. WHO/SEARO/Country Office for Bangladesh and Ministry of Health & Family Welfare, Bangladesh. World Health Organization, Strategic Plan for Surveillance and Prevention of Non Communicable Diseases in Bangladesh 2011–2015. SEARO. 2011. Available from:
http://www.searo.who.int/bangladesh/publications/strategic_plan_ncd/en/
. Accessed 29 Mar 2019.
2. Bhopal R, Unwin N, White M, et al. Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study. BMJ. 1999;319(7204):215–20.
3. Hasan M, Islam F, Rahaman MM, et al. An overview of the current status of prescribing pattern of statin molecules to prevent dyslipidemia in Bangladesh. IJIPSR. 2015;3(5):386–94.
4. Desai CS, Martin SS, Blumenthal RS. Non-cardiovascular effects associated with statins. BMJ. 2014;349:g3743.
5. Heart Protection Study Collaborative Group. Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals: a randomised controlled trial. Lancet. 2011;378(9808):2013–20.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献